Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-006667

Chief Financial Officer gave up 1,308 shares (to pay taxes)

  • Chief Financial Officer acquired 3,875 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ruffo Frank Chief Financial Officer 2020-02-03 Option exercise +3,875 170,675 D: show line 1 in the form
Ruffo Frank Chief Financial Officer 2020-02-03 Shares withheld for taxes −1,308 $1.28 $1,674 169,367 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ruffo Frank Chief Financial Officer 2020-02-03 Option exercise · Restricted Stock Units −3,875 7,750 D: show line 3 in the form
Loading xslF345X03/doc4.xml…